New Zealand - English - Medsafe (Medicines Safety Authority)

alcon laboratories australia pty ltd (nz) - hypromellose 5 mg/ml - eye drops, solution - 0.5 % - active: hypromellose 5 mg/ml excipient: benzalkonium chloride dibasic sodium phosphate monobasic sodium phosphate monohydrate purified water sodium chloride sodium citrate dihydrate

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

15ml dropper bottle -

Australia - English - Department of Health (Therapeutic Goods Administration)

carbachol -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - pilocarpine hydrochloride -

United States - English - NLM (National Library of Medicine)

alcon laboratories, inc. - atropine sulfate (unii: 03j5ze7ka5) (atropine - unii:7c0697dr9i) - atropine sulfate 10 mg in 1 ml - isopto® atropine 1% is indicated for: atropine sulfate ophthalmic solution should not be used in anyone who has demonstrated a previous hypersensitivity or known allergic reaction to any ingredient of the formulation because it may recur. risk summary there are no adequate and well-controlled studies with isopto® atropine 1% administration in pregnant women to inform a drug-associated risk. adequate animal development and reproduction studies have not been conducted with atropine sulfate. in humans, 1% atropine sulfate is systemically bioavailable following topical ocular administration [see clinical pharmacology (12.3)] . isopto® atropine 1% should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus. there is no information to inform risk regarding the presence of atropine in human milk following ocular administration of isopto® atropine 1% to the mother. the effects on breastfed infants and the effects on milk production are also unknown.  the developmental a

United States - English - NLM (National Library of Medicine)

alcon laboratories, inc. - pilocarpine hydrochloride (unii: 0ww6d218xj) (pilocarpine - unii:01mi4q9di3) - pilocarpine hydrochloride 10 mg in 1 ml - isopto® carpine is indicated for the:         none. pregnancy. category c. animal reproduction studies have not been conducted with pilocarpine hydrochloride. it is also not known whether pilocarpine hydrochloride can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. isopto® carpine should be given to a pregnant woman only if clearly needed. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when isopto® carpine is administered to a nursing woman. safety and effectiveness of pilocarpine hydrochloride ophthalmic solution in pediatric patients have been established. no overall differences in safety or effectiveness have been observed between elderly and younger patients.

Canada - English - Health Canada

novartis pharmaceuticals canada inc - pilocarpine hydrochloride - liquid - 1% - pilocarpine hydrochloride 1% - miotics

Canada - English - Health Canada

novartis pharmaceuticals canada inc - pilocarpine hydrochloride - liquid - 4% - pilocarpine hydrochloride 4% - miotics

Canada - English - Health Canada

novartis pharmaceuticals canada inc - pilocarpine hydrochloride - liquid - 2% - pilocarpine hydrochloride 2% - miotics